A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy

Launched by ROYAL COLLEGE OF SURGEONS, IRELAND · Jun 6, 2024

Keywords

ClinConnect Summary

This clinical trial is testing a new therapy to help improve walking abilities in children with Cerebral Palsy, a condition that affects movement and coordination. The study aims to find out if children and their families find this therapy helpful and easy to follow. It also looks at whether the children can complete all the therapy sessions, which total 30 hours over six weeks. Participants will share their feelings about the therapy through interviews at the end of the trial.

To participate, children aged between 2 and 18 must have a diagnosis of Cerebral Palsy and a specific walking goal they wish to achieve. They should be able to follow instructions and have a caregiver who can support them at home. However, children who have had recent surgery or certain medications, or who have additional severe cognitive challenges, may not be eligible. This trial is currently recruiting participants and is a great opportunity for families looking to improve their child’s walking performance in a supportive community setting.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Primary diagnosis of Cerebral Palsy (GMFCS Levels I-III)
• • Has a specific walking related goal
• • Has capacity to follow instruction
• • Has a primary caregiver who can support a home program
• Exclusion Criteria:
• • Has had surgery within 6 months of intervention start date
• • Has had botox/ baclofen within 3 months of intervention start date
• • Has a dual diagnosis that impacts ability to follow instruction
• • Has a significant cognitive impairment